ProKidney Corp.
NASDAQ:PROKBiotechnology
+$0.02 today
- Market cap
- $349.70M
- Beta
- 1.70
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$0.53
Volume 1.80M
Average 0.96M
Returns on capital
ProKidney Corp. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
6.8%
avg -135.9%
ROIC
-53.9%
avg -152.0%
ROA
-20.6%
avg -109.5%
Analysis
ROE is currently the strongest return metric at 6.8% versus its period average of -135.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Bruce Culleton | Chief Executive Officer & Director | USD 1.18M | 57 | 500.00K | 0.34% |
Todd C. Girolamo | Chief Legal Officer & Secretary | USD 725.1K | 61 | 0 | <0.01% |
James Coulston | Chief Financial Officer | USD 724.87K | 49 | 600.00K | 0.40% |
Darin J. Weber | Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access | — | 58 | 200.00K | 0.13% |
Joseph Stavas | Senior Vice President of Interventional Procedures | — | — | — | — |
Gregory Madison | Chief Commercial Officer | — | 59 | — | — |
Kenneth Locke | Chief Technical Officer | — | — | — | — |
Carla Poulson | Chief People Officer | — | — | — | — |
Emily Butler | Senior Vice President of Biometric | — | — | — | — |
Richard Williams | Chief Information Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 2, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
5
$751,209.41
Net Transaction Value
−$751,209.41
Net selling
Most Active
Pereira Brian JG
5 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 20, 26Aug 20, 2026 | Pereira Brian JG Direct | Sell | $38.4K$38,411.13 |
| Aug 19, 26Aug 19, 2026 | Pereira Brian JG Direct | Sell | $39K$38,972.38 |
| Aug 19, 26Aug 19, 2026 | Pereira Brian JG Indirect | Sell | $321.2K$321,202.62 |
| Aug 18, 26Aug 18, 2026 | Pereira Brian JG Direct | Sell | $38.2K$38,155.01 |
| Aug 18, 26Aug 18, 2026 | Pereira Brian JG Indirect | Sell | $314.5K$314,468.27 |
Summary
Insiders reported 0 buys worth $0.00 and 5 sells worth $751,209.41 over the last 12 months. That adds up to net selling of $751,209.41. Pereira Brian JG was the most active insider with 5 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +207.7% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Forward estimates point to Revenue at +207.7% (5yr), giving you a quick read on expected growth from here.
Competitors
Who does ProKidney Corp. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about PROK's management, answered from reported figures.
Who manages PROK?
ProKidney Corp. (PROK) lists 10 active executives. The top listed executive is Darin J. Weber, Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access.
Are PROK insiders buying or selling?
Recent insider activity shows net buying of $145.62M.
Continue the stock analysis
Jump to another research area for this company.